Updates are available Correction dated 2021-09-01
Click to view Correction: https://doi.org/10.1038/s41398-021-01449-w
-
Authors
Chaudhry, I. B.
Husain, M. O.
Khoso, A. B.
Husain, M. I. https://orcid.org/0000-0001-5771-5750
Buch, M. H.
Kiran, T.
Fu, B.
Bassett, P. https://orcid.org/0000-0001-7830-4563
Qurashi, I.
ur Rahman, R.
Baig, S.
Kazmi, A.
Corsi-Zuelli, F. https://orcid.org/0000-0001-9202-3987
Haddad, P. M.
Deakin, B. https://orcid.org/0000-0002-2750-962X
Husain, N.
- License Information
-
More Information
Article History
Received: 22 April 2020
Revised: 12 September 2020
Accepted: 9 October 2020
First Online: 30 November 2020
Change Date: 1 September 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41398-021-01449-w
Conflict of interest
: I.B.C. and N.H. have given lectures and advice to Eli Lilly, Bristol Myers Squibb, Lundbeck, Astra Zeneca and Janssen pharmaceuticals for which they or their employing institution have been reimbursed. M.I.H. is a PI for a trial sponsored by COMPASS Pathways Limited for which he receives salary support. M.I.H. has been awarded grants from the Brain and Behavior Research Foundation, IAMGOLD Foundation, Physician’s Services Incorporated Foundation and Stanley Medical Research Institute. M.I.H., I.B.C. and N.H. were previously trustees of the Pakistan Institute of Learning and Living. B.D. has worked as scientific consultant to Autifony in the last 3 years and has share options in P1vtal.com.
